The importance and challenge of pediatric trials of hemophilia drugs

被引：3
|
作者：
Mentzer, Dirk [1 ,2 ]
Desfontaine, Emilie [1 ]
Tomasi, Paolo A. [1 ]
机构：
[1] European Med Agcy, London, England
[2] Paul Ehrlich Inst, Langen, Germany
来源：
NATURE MEDICINE | 2014年 / 20卷 / 05期
关键词：
FACTOR-VIII PRODUCTS; CLINICAL DEVELOPMENT; EUROPEAN GUIDELINES; EVOLUTION;
D O I：
10.1038/nm.3546
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：465 / 465
页数：1
相关论文
共 50 条
  • [1] The importance and challenge of pediatric trials of hemophilia drugs
    Dirk Mentzer
    Emilie Desfontaine
    Paolo A Tomasi
    Nature Medicine, 2014, 20 : 465 - 465
  • [2] The importance and challenge of pediatric trials of hemophilia drugs Reply
    Peyvandi, Flora
    Rosendaal, Frits R.
    O'Mahony, Brian
    Mannucci, Pier Mannuccio
    NATURE MEDICINE, 2014, 20 (05) : 466 - 466
  • [3] Reply to: The importance and challenge of pediatric trials of hemophilia drugs
    Flora Peyvandi
    Frits R Rosendaal
    Brian O'Mahony
    Pier Mannuccio Mannucci
    Nature Medicine, 2014, 20 : 466 - 466
  • [4] The importance of randomized controlled trials in pediatric cardiology
    Gidding, Samuel S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (10): : 1214 - 1216
  • [5] Emerging drugs for hemophilia A: insights into phase II and III clinical trials
    Kizilocak, Hande
    Young, Guy
    EXPERT OPINION ON EMERGING DRUGS, 2021, 26 (04) : 337 - 350
  • [6] Accrual in supportive care trials in pediatric oncology, a challenge!
    Schoot, R. A.
    van Ommen, C. H.
    Caron, H. N.
    Tissing, W. J. E.
    van de Wetering, M. D.
    SUPPORTIVE CARE IN CANCER, 2012, 20 (12) : 3149 - 3153
  • [7] Accrual in supportive care trials in pediatric oncology, a challenge!
    R. A. Schoot
    C. H. van Ommen
    H. N. Caron
    W. J. E. Tissing
    M. D. van de Wetering
    Supportive Care in Cancer, 2012, 20 : 3149 - 3153
  • [8] A Challenge for Hemophilia Treatment: Hemophilia and Cancer
    Koc, Basak
    Zulfikar, Bulent
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (01) : E29 - E32
  • [9] The importance of phase I/II trials in pediatric oncology
    MacArthur, CA
    Vietti, T
    INVESTIGATIONAL NEW DRUGS, 1996, 14 (01) : 33 - 35
  • [10] The challenge of cardiovascular prevention in the elderly: importance of randomized clinical trials
    Crea, Filippo
    EUROPEAN HEART JOURNAL, 2022, 43 (21) : 1997 - 2000
12345